Safex Chemicals IPO vs Shadowfax Technologies IPO

Comparison between Safex Chemicals IPO and Shadowfax Technologies IPO.

IPO Details

Safex Chemicals IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Shadowfax Technologies IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Safex Chemicals IPO is up to ₹0.00 Cr whereas the issue size of the Shadowfax Technologies IPO is up to ₹1,907.27 Cr. The final issue price of Safex Chemicals IPO is and of Shadowfax Technologies IPO is ₹124.00 per share.

 Safex Chemicals IPOShadowfax Technologies IPO
Face Value₹1 per share₹10 per share
Issue Price (Lower)₹118.00 per share
Issue Price (Upper)₹124.00 per share
Issue Price (Final)₹124.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size120 shares
Fresh Issue Size0 shares8,06,45,160 shares
Fresh Issue Size (Amount)up to ₹450.00 Crup to ₹1,000.00 Cr
OFS Issue Size3,57,34,818 shares7,31,66,854 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹907.27 Cr
Issue Size Total0 shares15,38,12,014 shares
Issue Size Total (Amount)up to ₹0.00 Crup to ₹1,907.27 Cr

IPO Timetable

Safex Chemicals IPO opens on , while Shadowfax Technologies IPO opens on Jan 20, 2026. The closing date of Safex Chemicals IPO and Shadowfax Technologies IPO is , and Jan 22, 2026, respectively.

Financials & KPIs

Safex Chemicals IPO P/E ratio is , as compared to Shadowfax Technologies IPO P/E ratio of 1017.96.

 Safex Chemicals IPOShadowfax Technologies IPO
Financials

Company Financials (Restated Consolidated)

Safex Chemicals (India) Ltd.'s revenue increased by 13% and profit after tax (PAT) rose by 37% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets2,084.361,923.431,905.17
Total Income1,605.821,417.661,167.47
Profit After Tax-14.29-22.79-1.02
EBITDA233.03118.65149.06
NET Worth611.46626.15648.88
Reserves and Surplus656.47657.84664.85
Total Borrowing830.39677.09680.22
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended30 Sep 202531 Mar 202531 Mar 202431 Mar 2023
Assets1,453.161,259.26786.14442.73
Total Income1,819.802,514.661,896.481,422.89
Profit After Tax21.046.06-11.88-142.64
EBITDA64.3456.1911.37-113.47
NET Worth693.53660.43421.78176.32
Reserves and Surplus281.26248.16172.47171.20
Total Borrowing147.44132.2340.3366.69
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)54.319.13
Promoter Shareholding (Post-Issue)16.49
P/E Ratio1017.96
Market Cap₹7168.85 Cr.
ROE-2.12%
ROCE10.65%
Debt/Equity0.950.20
EPS₹0.12
RoNW-2.34%0.97

Shares Offered

In the Safex Chemicals IPO Retail Individual Investors (RII) are offered 0 shares while in Shadowfax Technologies IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Safex Chemicals IPO and 4,60,22,638 shares in Shadowfax Technologies IPO.

 Safex Chemicals IPOShadowfax Technologies IPO
Anchor Investor Reservation0 shares6,90,33,955 shares
Market Maker Reservation0 shares0 shares
QIB0 shares4,60,22,638 shares
NII0 shares2,30,11,318 shares
RII0 shares1,53,40,878 shares
Employee0 shares4,03,225 shares
Others
Total0 shares15,38,12,014 shares

Bids Received (Subscription)

Safex Chemicals IPO subscribed in total, whereas Shadowfax Technologies IPO subscribed 2.86x.

Compare with others

Compare: